NCT03674411 2026-01-06
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Phase 2 Active not recruiting
Masonic Cancer Center, University of Minnesota
University of California, Los Angeles
Altamash Institute of Dental Medicine
Rochester Skin Lymphoma Medical Group, PLLC
University of Washington
University of Arizona
Fudan University
Fudan University